QT
IBRX icon

Quantbot Technologies’s ImmunityBio IBRX Stock Holding History

Quantbot Technologies’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,206
Closed -$15.3K – 1906
2025
Q3 		$15.3K Buy
+6,206
New +$16K ﹤0.01% 1615
2025
Q1 		– Sell
-4,722
Closed -$12.1K – 1658
2024
Q4 		$12.1K Sell
4,722
-33,690
-88% -$140K ﹤0.01% 1374
2024
Q3 		$143K Buy
+38,412
New +$178K 0.01% 1101
2022
Q4 		– Sell
-12,424
Closed -$61K – 1859
2022
Q3 		$61K Sell
12,424
-45,100
-78% -$206K ﹤0.01% 1209
2022
Q2 		$213K Buy
57,524
+28,524
+98% +$115K 0.02% 896
2022
Q1 		$162K Sell
29,000
-14,203
-33% -$87.1K 0.01% 927
2021
Q4 		$262K Buy
+43,203
New +$325K 0.02% 667

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Quantbot Technologies's IBRX Position: Q4 2025 in Review

Quantbot Technologies sold out of ImmunityBio (IBRX) in Q4 2025, closing a stake of 6,206 shares — an estimated $15.3K sold.

Quantbot Technologies first reported a position in IBRX in Q4 2021 and held it in 7 quarters. The position peaked at $262K in Q4 2021. 276 funds tracked by Wall St. Rank hold IBRX as of Q4 2025.

  • Quantbot Technologies reported no remaining ImmunityBio position as of Q4 2025 after selling out during the quarter.
  • Quantbot Technologies sold 6,206 ImmunityBio shares in Q4 2025, an estimated $15.3K.
  • Quantbot Technologies first reported a position in ImmunityBio in Q4 2021 and held it in 7 quarters.
  • Quantbot Technologies's ImmunityBio position peaked at $262K in Q4 2021.
  • 276 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2025.

Based on Quantbot Technologies's 13F filing for Q4 2025, filed 10 Feb 2026.